Clinical Outcomes and Molecular Predictors of Pembrolizumab (Keytruda) as a PD-1 Immune Checkpoint Inhibitor in Advanced and Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis

This systematic review evaluates the clinical outcomes and molecular predictors of response to pembrolizumab in patients with advanced and metastatic cervical cancer. We adhered to the PRISMA guidelines for systematic reviews, conducting a database search in PubMed, Scopus, and Embase. The eligibili...

詳細記述

書誌詳細

主要な著者:	Lavinia Balan, Anca Maria Cimpean, Prashant Sunil Nandarge, Bogdan Sorop, Catalin Balan, Madalina Alexandra Balica, Felix Bratosin, Simona Brasoveanu, Madalina Boruga, Laurentiu Pirtea
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2024-05-01
シリーズ:	Biomedicines
主題:	oncology gynecology cervical cancer systematic review
オンライン･アクセス:	https://www.mdpi.com/2227-9059/12/5/1109
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!